Dr. Elisa Scarselli, CSO of Nouscom, invited speaker Immunotherapy in Hematological Malignancies 2023 – CCITC, Cuneo May 18-20  - Nouscom

Dr. Elisa Scarselli, CSO of Nouscom, invited speaker Immunotherapy in Hematological Malignancies 2023 – CCITC, Cuneo May 18-20 

By ef

Posted 10/25/2023

PRESENTATION TITLE: Identifying biomarkers associated with clinical response to neoantigen-based cancer vaccines.

Please find the full report below:

Read more

Recent Posts

Nouscom Raises €67.5 million ($72 million) in Oversubscribed  Series C Financing Round
Dr. Morena D’Alise (VP of Immunology) is presenting at the SITC Annual Meeting 2023, San Diego November 1-3
Dr. Elisa Scarselli (Nouscom CSO) invited speaker at EHTG European Hereditary Tumour Group 2023, Vilnius September 28 – October 1st
Dr. Elisa Scarselli (CSO) invited speaker at Vaccines Europe 2023, Berlin September 13-15

error: Content is protected !!!